Myriade
Private Company
Total funding raised: $2.5M
Overview
Myriade is a Paris-based company commercializing a proprietary optical technology, Interferometric Light Microscopy (ILM), for nanoparticle characterization. Its flagship product, Videodrop, provides rapid, single-particle analysis of size and concentration, addressing critical quality control needs in advanced biomanufacturing and nanomedicine research. The company leverages deep academic roots from the Langevin Institute and targets high-growth sectors like cell and gene therapy (viral vectors) and mRNA delivery (LNPs). As a private, early-revenue company, Myriade's strategy is centered on instrument sales and establishing its technology as a standard tool in research and bioproduction workflows.
Technology Platform
Interferometric Light Microscopy (ILM): A label-free optical imaging technology that transforms a standard microscope into an interferometer. It uses a LED light source, a high dynamic range camera, and proprietary AI/software algorithms to detect interference patterns from single nanoparticles, enabling rapid measurement of size, concentration, and aggregation kinetics from a micro-volume sample.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Myriade competes in the nanoparticle analysis market against established techniques like Dynamic Light Scattering (DLS, e.g., Malvern Panalytical) and Nanoparticle Tracking Analysis (NTA, e.g., Malvern's NanoSight). Key differentiators are Videodrop's speed, single-particle resolution on heterogeneous samples, kinetic aggregation data, and minimal sample volume. It positions itself as a complementary or superior alternative for specific, high-value applications in biotherapeutics.